Health diabetes experts are highlighting new treatment options for those diagnosed with type 2 diabetes, including informed ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year ...

Diabetes affects millions worldwide, often triggering complications such as insulin resistance and fatty liver disease. To ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

The rise of GLP-1s, which were initially approved for diabetes management and later for obesity treatment, underscores this ...

Zepbound, Mounjaro and liraglutide are part of the class of weight loss medications called GLP-1s, which have exploded in ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.

A team of scientists has found new clues that could change how ... Metformin, a common treatment for type 2 diabetes, is at the heart of this research. Scientists found it may also help slow ...

Broad access to new obesity drugs leads to longer, healthier lives, delivering a substantial societal return on investment, ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.